Everolimus Plus Octreotide Long-Acting Repeatable in Patients With Colorectal Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT-2 Study

INTRODUCTION. The incidence of colorectal neuroendocrine tumors (NETs) is increasing, and patients with this disease have particularly poor prognoses. Treatment options are limited, and survival times have not improved in the past decade. METHODS. A post hoc analysis of the efficacy and tolerability...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Castellano, Daniel, Bajetta, Emilio, Panneerselvam, Ashok, Saletan, Stephen, Kocha, Walter, O'Dorisio, Thomas, Anthony, Lowell B., Hobday, Timothy
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2013
Assuntos:
Gastrointestinal Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3556255/
https://ncbi.nlm.nih.gov/pubmed/23263288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0263
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados